1 buyer · 3 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 1 sold
Latest: sale, 2025-10-31
Planned sales (Form 144), 90 days
$3.9M
3 notices
Northern Trust insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, NORTHERN TRUST CORP insiders sold a net $4.4M of stock across 117 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Nobody has filed for crossing 5%. That is a fact, not missing data.
NTRS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Levy Susan Cohen
Filed 2026-10-26
$661.6K
Levy Susan Cohen
Filed 2026-10-23
$2.9M
Thomas A South
Filed 2026-08-19
$333.7K
NTRS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Genter Dividend Income Fund
$2.4M position · as of 2026-07-31
4.7%
Invesco KBW Bank ETF
$196.0M position · as of 2026-05-31
3.7%
ROCK OAK CORE GROWTH FUND
$451.1K position · as of 2026-07-31
3.3%
Victory Pioneer Mid Cap Value Fund
$24.7M position · as of 2026-07-31
3.2%
Victory Pioneer Mid Cap Value VCT Portfolio
$3.5M position · as of 2026-06-30
3.1%
Schwab Ariel Opportunities ETF
$797.2K position · as of 2026-06-30
3.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Northern Trust Corporation Federal Political Action Committee (Northern Trust Federal Pac)
Cycle 2026 · $42K spent
$35.7K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Mr. O’Grady
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$10.1M
$21.6M
$4.3M
+71%
+96%
2024
$10.9M
$21.3M
$4.0M
+25%
+48%
2023
$10.2M
$11.2M
$5.4M
-1%
+8%
2022
$10.8M
$4.0M
$5.7M
+0%
+9%
2021
$10.4M
$18.5M
$4.4M
+32%
+38%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.4M sold by insiders over 180 days, 513 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $3.9M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$8.3B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM NTRS
FY Dec 2025
$8.1B
FY Dec 2024
$8.3B
FY Dec 2023
$6.8B
FY Dec 2022
$6.8B
FY Dec 2021
$6.5B
Jun 2026
$1.3B
Mar 2026
$1.3B
Dec 2025
$4.4B
Sep 2025
$1.3B
Jun 2025
$1.2B
Mar 2025
$1.2B
Dec 2024
$4.8B
Sep 2024
$1.2B
At each fiscal year end
Single quarter
Net margin, TTM
+26.9%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM NTRS
FY Dec 2025
+21.5%
FY Dec 2024
+24.5%
FY Dec 2023
+16.3%
FY Dec 2022
+19.8%
FY Dec 2021
+23.9%
Jun 2026
+58.7%
Mar 2026
+39.2%
Dec 2025
+10.6%
Sep 2025
+36.2%
Jun 2025
+34.2%
Mar 2025
+32.3%
Dec 2024
+9.5%
Sep 2024
+38.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
$445.3M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM NTRS
FY Dec 2025
$5.5B
FY Dec 2024
-$587.5M
FY Dec 2023
$2.5B
FY Dec 2022
$2.3B
FY Dec 2021
$1.3B
Jun 2026
-$90.3M
Mar 2026
-$329.4M
Dec 2025
$355.6M
Sep 2025
$509.4M
Jun 2025
$1.9B
Mar 2025
$2.7B
Dec 2024
-$2.7B
Sep 2024
$585.4M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity NTRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt NTRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+17.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity NTRS
FY Dec 2025
+13.5%
FY Dec 2024
+16.5%
FY Dec 2023
+9.6%
FY Dec 2022
+11.5%
FY Dec 2021
+13.0%
Jun 2026
+17.1%
Mar 2026
+14.5%
Dec 2025
+13.5%
Sep 2025
+13.4%
Jun 2025
+13.6%
Mar 2025
+17.7%
Dec 2024
+16.5%
Sep 2024
+13.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets NTRS
FY Dec 2025
+1.0%
FY Dec 2024
+1.3%
FY Dec 2023
+0.7%
FY Dec 2022
+0.8%
FY Dec 2021
+0.9%
Jun 2026
+1.3%
Mar 2026
+1.1%
Dec 2025
+1.0%
Sep 2025
+1.1%
Jun 2025
+1.1%
Mar 2025
+1.4%
Dec 2024
+1.3%
Sep 2024
+1.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital NTRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed NTRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
17.75x
close 2026-10-26 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing NTRS
FY Dec 2025
15.63x
FY Dec 2024
10.48x
FY Dec 2023
16.61x
FY Dec 2022
14.41x
FY Dec 2021
16.75x
Jun 2026
18.20x
Mar 2026
14.61x
Dec 2025
15.63x
Sep 2025
15.69x
Jun 2025
14.90x
Mar 2025
9.20x
Dec 2024
10.48x
Sep 2024
11.20x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value NTRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+1.4%
TTM free cash flow over market value at close 2026-10-26
FCF yield NTRS
FY Dec 2025
+21.1%
FY Dec 2024
-2.9%
FY Dec 2023
+14.4%
FY Dec 2022
+12.3%
FY Dec 2021
+5.1%
Jun 2026
+1.4%
Mar 2026
+9.3%
Dec 2025
+21.1%
Sep 2025
+9.5%
Jun 2025
+10.3%
Mar 2025
+18.8%
Dec 2024
-2.9%
Sep 2024
+27.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -11%, PEG needs growth
PEG, trailing NTRS
FY Dec 2025
n/a
FY Dec 2024
0.11x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.54x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
2.34x
Jun 2025
0.91x
Mar 2025
0.07x
Dec 2024
0.11x
Sep 2024
0.21x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
NTRS ranks highest on profitability (82nd percentile) and risk and compliance (69th), and lowest on insider conviction (29th), among Banks peers.
Profitability
82
Inputs
Return on equity+17.1% · 96 pct, sector of 327
Return on assets+1.3% · 68 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
49
Inputs
Revenue growth, YoY+6.1% · 49 pct, sector of 151
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
29
Inputs
Net Form 4 buying (codes P and S), 180d-$4.4M · 12 pct, sector of 273
Insider buyers, 180d1 · 47 pct, sector of 273
Institutional and government
65
Inputs
Funds adding, latest quarter513 · 96 pct, sector of 257
Congress net buyers, 365d0 · 38 pct, sector of 33
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$670K · 63 pct, universe of 1,062
Risk and compliance
69
Inputs
Short interest, % of float+2.2% · 59 pct, sector of 374
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+5.5% · 78 pct, sector of 127
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
NTRS filings, in plain words
Are Northern Trust insiders buying or selling NTRS?
In the 180 days to 2026-10-28, Northern Trust insiders were net sellers, a net $4.4M: $83.2K of purchases and $4.5M of sales reported on Form 4, by 1 buyer and 3 sellers.
Have members of Congress traded NTRS?
Yes. In the year to 2026-10-28, 1 House member disclosed buying NTRS and 1 House member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31.
Are there planned insider sales of NTRS?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $3.9M of stock; the latest, by Levy Susan Cohen, was filed 2026-10-26.
Read the full summary
In the 180 days to 2026-10-28, Northern Trust insiders were net sellers of NTRS, a net $4.4M across purchases and sales reported on Form 4 by 1 buyer and 3 sellers. Sales outweighed purchases more than tenfold by value. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-28, 1 member of Congress disclosed buying NTRS and 1 member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $3.9M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.